24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical genetics<br />

CM in monozygotic twins where only one is affected, suggesting that<br />

M-CM is due to a post-zygotic event .<br />

P01.316<br />

study <strong>of</strong> the aortic risk associated with FBN mutations from<br />

an international study <strong>of</strong> 1013 patients with marfan syndrome or<br />

related type I fibrillinopathy<br />

L. Faivre 1 , G. Collod-Beroud 2 , B. Loeys 3 , A. Child 4 , C. Binquet 5 , E. Gautier 5 , B.<br />

Callaewert 3 , E. Arbustini 6 , K. Mayer 7 , M. Arslan-Kirchner 8 , C. Beroud 9 , M. Claustres<br />

9 , C. Bonithon-Kopp 5 , L. Ades 10 , J. De Backer 3 , P. Coucke 3 , U. Francke 11 , A.<br />

De Paepe 3 , C. Boileau 12 , G. Jondeau 13 ;<br />

1 Departement de Genetique, Dijon, France, 2 INSERM, U827, Montpellier,<br />

France, 3 Center for Medical <strong>Genetics</strong>, Ghent, Belgium, 4 4 Department <strong>of</strong> Cardiological<br />

Sciences, St. George’s Hospital, London, United Kingdom, 5 Centre<br />

d’investigation clinique – épidémiologie clinique/essais cliniques, Dijon, France,<br />

6 Molecular Diagnostic Unit, Policlinico San Matteo, Pavia, Italy, 7 Center for<br />

<strong>Human</strong> <strong>Genetics</strong> and Laboratory Medicine, Martinsried, Germany, 8 Institut für<br />

<strong>Human</strong>genetik, Hannover, Germany, 9 Laboratoire de Génétique Moléculaire,<br />

Hôpital Arnault de Villeneuve, Montpellier, France, 10 Marfan Research Group,<br />

The Children’s Hospital at Westmead, Sidney, Australia, 11 Departments <strong>of</strong> <strong>Genetics</strong><br />

and Pediatrics, Stanford, CA, United States, 12 Laboratoire de Génétique<br />

moléculaire, Hôpital Ambroise Paré, Boulogne, France, 13 Centre de Référence<br />

Maladie de Marfan, Hôpital Bichat, Paris, France.<br />

In order to better describe the aortic risk associated with mutations<br />

in the FBN1 gene, we took advantage <strong>of</strong> a series <strong>of</strong> 1013 genotyped<br />

probants carrying Marfan syndrome or another type I fibrillinopathy,<br />

recruited for a genotype-phenotype correlation study . At 40 years<br />

<strong>of</strong> age, the cumulative probability <strong>of</strong> presenting an ascending aortic<br />

dilatation (AAD) was 75% (95%-CI=72%-78%), 26% (95%-CI=22%-<br />

31%) for ascending aortic dissection and 41% (95%-CI=36%-46%)<br />

for cardiac surgery . The cumulative probability <strong>of</strong> presenting AAD<br />

was higher in males than in females (80% [95%-CI=76%-83%] at 40<br />

years <strong>of</strong> age in males versus 70% [95%-CI=65%-75%] in females;<br />

p=0 .0036) . An higher risk <strong>of</strong> aortic surgery was also observed in males<br />

(46% [95%-CI=39%-52%] versus 34% [95%-CI=27%-42%] in females<br />

; p=0 .0002) . The study <strong>of</strong> the paediatric cohort (n=320) showed that<br />

aortic complications remained an exception, with a 1% risk <strong>of</strong> aortic<br />

dissection and a 5% risk <strong>of</strong> aortic surgery at 10 years <strong>of</strong> age . Adult<br />

patients diagnosed during childhood had a higher risk <strong>of</strong> developing<br />

AAD (81% [95%-CI=73%-88%] at 40 years <strong>of</strong> age) than patients diagnosed<br />

in adulthood (65% [95%-CI=60%-69%], p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!